StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Skinvisible

Skinvisible has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Skinvisible figures

See a number that looks wrong?